Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
---|---|---|---|---|---|---|---|---|---|
Patent 8216289 was granted and assigned to DUSA Pharmaceuticals on July, 2012 by the United States Patent and Trademark Office. | 8216289 | July 10, 2012 | |||||||
Patent 8030836 was granted and assigned to DUSA Pharmaceuticals on October, 2011 by the United States Patent and Trademark Office. | 8030836 | October 4, 2011 | |||||||
Patent 6958035 was granted and assigned to DUSA Pharmaceuticals on October, 2005 by the United States Patent and Trademark Office. | 6958035 | October 25, 2005 | |||||||
Patent 10357567 was granted and assigned to DUSA Pharmaceuticals on July, 2019 by the United States Patent and Trademark Office. | 10357567 | July 23, 2019 | |||||||
Patent 9597150 was granted and assigned to DUSA Pharmaceuticals on March, 2017 by the United States Patent and Trademark Office. | 9597150 | March 21, 2017 | |||||||
Patent D613872 was granted and assigned to DUSA Pharmaceuticals on April, 2010 by the United States Patent and Trademark Office. | D613872 | April 13, 2010 | |||||||
Patent 9241957 was granted and assigned to DUSA Pharmaceuticals on January, 2016 by the United States Patent and Trademark Office. | 9241957 | January 26, 2016 | |||||||
Patent 8758418 was granted and assigned to DUSA Pharmaceuticals on June, 2014 by the United States Patent and Trademark Office. | 8758418 | June 24, 2014 | |||||||
Patent 9339540 was granted and assigned to DUSA Pharmaceuticals on May, 2016 by the United States Patent and Trademark Office. | 9339540 | May 17, 2016 | |||||||
Patent 8015653 was granted and assigned to DUSA Pharmaceuticals on September, 2011 by the United States Patent and Trademark Office. | 8015653 | September 13, 2011 | |||||||
Patent 10603508 was granted and assigned to DUSA Pharmaceuticals on March, 2020 by the United States Patent and Trademark Office. | 10603508 | March 31, 2020 | |||||||
Patent 10589122 was granted and assigned to DUSA Pharmaceuticals on March, 2020 by the United States Patent and Trademark Office. | 10589122 | March 17, 2020 | |||||||
Patent 9561276 was granted and assigned to DUSA Pharmaceuticals on February, 2017 by the United States Patent and Trademark Office. | 9561276 | February 7, 2017 | |||||||
Patent 9387341 was granted and assigned to DUSA Pharmaceuticals on July, 2016 by the United States Patent and Trademark Office. | 9387341 | July 12, 2016 | |||||||
Patent D768291 was granted and assigned to DUSA Pharmaceuticals on October, 2016 by the United States Patent and Trademark Office. | D768291 | October 4, 2016 | |||||||
Patent 9723991 was granted and assigned to DUSA Pharmaceuticals on August, 2017 by the United States Patent and Trademark Office. | 9723991 | August 8, 2017 | |||||||
Patent 8609073 was granted and assigned to DUSA Pharmaceuticals on December, 2013 by the United States Patent and Trademark Office. | 8609073 | December 17, 2013 | |||||||
Patent 10029116 was granted and assigned to DUSA Pharmaceuticals on July, 2018 by the United States Patent and Trademark Office. | 10029116 | July 24, 2018 | |||||||
Patent 11904180 was granted and assigned to DUSA Pharmaceuticals on February, 2024 by the United States Patent and Trademark Office. | 11904180 | February 20, 2024 | |||||||
Patent 11890440 was granted and assigned to DUSA Pharmaceuticals on February, 2024 by the United States Patent and Trademark Office. | 11890440 | February 6, 2024 |